These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 30724166)

  • 1. What still remains missing from participants' selection criteria in clinical trials and systematic reviews?
    Miller CS; Carrasco-Labra A; Farag AM; Ariyawardana A; Albuquerque R; Chmieliauskaite M; Glick M
    J Am Dent Assoc; 2018 Nov; 149(11):931-934. PubMed ID: 30724166
    [No Abstract]   [Full Text] [Related]  

  • 2. Study-design selection criteria in systematic reviews of effectiveness of health systems interventions and reforms: A meta-review.
    Rockers PC; Feigl AB; Røttingen JA; Fretheim A; de Ferranti D; Lavis JN; Melberg HO; Bärnighausen T
    Health Policy; 2012 Mar; 104(3):206-14. PubMed ID: 22325150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intervention synthesis: a missing link between a systematic review and practical treatment(s).
    Glasziou PP; Chalmers I; Green S; Michie S
    PLoS Med; 2014 Aug; 11(8):e1001690. PubMed ID: 25117057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporting and Handling of Missing Participant Data in Systematic Reviews of Kidney Transplant Studies.
    Budhiraja P; Kalot MA; Alayli AE; Dimassi A; Kaplan B; Chakkera HA; Mustafa RA
    Transplantation; 2021 Aug; 105(8):1708-1717. PubMed ID: 33093406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential impact of missing outcome data on treatment effects in systematic reviews: imputation study.
    Kahale LA; Khamis AM; Diab B; Chang Y; Lopes LC; Agarwal A; Li L; Mustafa RA; Koujanian S; Waziry R; Busse JW; Dakik A; Schünemann HJ; Hooft L; Scholten RJ; Guyatt GH; Akl EA
    BMJ; 2020 Aug; 370():m2898. PubMed ID: 32847800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A guidance was developed to identify participants with missing outcome data in randomized controlled trials.
    Kahale LA; Guyatt GH; Agoritsas T; Briel M; Busse JW; Carrasco-Labra A; Khamis AM; Zhang Y; Hooft L; Scholten RJPM; Akl EA
    J Clin Epidemiol; 2019 Nov; 115():55-63. PubMed ID: 31299357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical analysis and handling of missing data in cluster randomised trials: protocol for a systematic review.
    Fiero M; Huang S; Bell ML
    BMJ Open; 2015 May; 5(5):e007378. PubMed ID: 25971707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic survey shows that reporting and handling of missing outcome data in networks of interventions is poor.
    Spineli LM; Yepes-Nuñez JJ; Schünemann HJ
    BMC Med Res Methodol; 2018 Oct; 18(1):115. PubMed ID: 30355280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A process for prioritising systematic reviews in tinnitus.
    Sereda M; McFerran D; Axon E; Baguley DM; Hall DA; Potgieter I; Cima R; Cox S; Hoare DJ
    Int J Audiol; 2020 Aug; 59(8):640-646. PubMed ID: 32134348
    [No Abstract]   [Full Text] [Related]  

  • 10. Poor compliance of clinical trial registration among trials included in systematic reviews: a cohort study.
    Lindsley K; Fusco N; Teeuw H; Mooij E; Scholten R; Hooft L
    J Clin Epidemiol; 2021 Apr; 132():79-87. PubMed ID: 33333165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials with sequential analysis that were early-stopped: How to interpret them?
    Garegnani LI; Arancibia M; Madrid E; Franco JVA
    Medwave; 2020 Jun; 20(5):e7930. PubMed ID: 32603319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating non-randomised intervention studies.
    Deeks JJ; Dinnes J; D'Amico R; Sowden AJ; Sakarovitch C; Song F; Petticrew M; Altman DG; ;
    Health Technol Assess; 2003; 7(27):iii-x, 1-173. PubMed ID: 14499048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design can limit PRECIS-2 retrospective assessment of the clinical trial explanatory/pragmatic features.
    Dal-Ré R; de Boer A; James SK
    J Clin Epidemiol; 2020 Oct; 126():193-201. PubMed ID: 32325221
    [No Abstract]   [Full Text] [Related]  

  • 14. Methodological challenges in studying the COVID-19 pandemic crisis.
    Knottnerus JA; Tugwell P
    J Clin Epidemiol; 2020 May; 121():A5-A7. PubMed ID: 32336471
    [No Abstract]   [Full Text] [Related]  

  • 15. Getting the "balance" right in clinical trials.
    Abdel Shaheed C; Blyth F; Furmage AM; Stanaway F
    BMJ; 2021 Nov; 375():n2869. PubMed ID: 34819335
    [No Abstract]   [Full Text] [Related]  

  • 16. Does acupuncture have a place as an adjunct treatment during pregnancy? A review of randomized controlled trials and systematic reviews.
    Smith CA; Cochrane S
    Birth; 2009 Sep; 36(3):246-53. PubMed ID: 19747272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting quality and transparency in clinical research.
    Ramstrand N; Fatone S; Dillon MP; Hafner BJ
    Prosthet Orthot Int; 2019 Oct; 43(5):474-477. PubMed ID: 31592737
    [No Abstract]   [Full Text] [Related]  

  • 18. PRECIS-2 for retrospective assessment of RCTs in systematic reviews.
    Zwarenstein M; Thorpe K; Treweek S; Loudon K
    J Clin Epidemiol; 2020 Oct; 126():202-206. PubMed ID: 32565215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The timing and frequency of trial inclusion in systematic reviews of type 2 diabetes drugs was associated with trial characteristics.
    Dunn AG; Orenstein L; Coiera E; Mandl KD; Bourgeois FT
    J Clin Epidemiol; 2019 May; 109():62-69. PubMed ID: 30708175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of study designs.
    Aquilina J; Neves JB; Tran MG
    Br J Hosp Med (Lond); 2020 May; 81(5):1-6. PubMed ID: 32468947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.